← Back to Search

Smoking Cessation Program for Lung Cancer Prevention

N/A

Recruiting

Led By Matthew Triplette

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

AIM 1, COMMUNITY ORGANIZATION LEADERS: Age minimum of 18

As of Jan 2022: aged 50-80 years, at least 20 pack-year smoking history, and currently smoke tobacco cigarettes [as this intervention is based around current cigarette smokers (as defined above)], former cigarette smokers not included in this Aim

Must not have

AIM 1: Non-English speaking participants

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is developing a tailored screening and smoking cessation program for the LGBTQ community in Seattle to help them quit smoking and prevent lung cancer.

Who is the study for?

This trial is for LGBTQ individuals in Seattle aged 50-80 who currently smoke or have a history of heavy smoking, aiming to improve lung cancer screening and cessation support. Healthcare providers serving this community and leaders involved with LGBTQ organizations are also eligible.

What is being tested?

The program being tested includes patient navigation, questionnaires, a smoking cessation intervention, and carbon monoxide measurement to tailor lung cancer screening and help the LGBTQ community quit smoking.

What are the potential side effects?

There may not be direct side effects from participating as it's more about support and monitoring rather than medication. However, quitting smoking can lead to withdrawal symptoms like irritability, cravings, or difficulty concentrating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am at least 18 years old.

Select...

I am between 50-80 years old, have smoked for 20 years or more, and currently smoke.

Select...

I am between 50 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not speak English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of patient navigation and smoking cessation interventions (Aim 3)

Effectiveness of navigation visit(s): knowledge (Aim 3)

Effectiveness of navigation visit(s): smoking cessation (Aim 3)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Health services research (patient navigation intervention)Experimental Treatment4 Interventions

Participants receive a patient navigation intervention consisting of a series of points of contact (mostly via telephone) between the PN/TTS and includes: 1) An introduction and enrollment in LCS, 2) facilitation of a SDM visit with the LCS-dedicated nurse practitioner, 3) individual assessment of barriers and facilitators to in-person low-dose CT screening, 4) explanation of results and needed follow-up, and 5) follow-up reminders. Participants also undergo carbon monoxide measurement by exhaling into a disposable monitor for 10 seconds at the initial visit and the post-intervention visit. The PN may also provide an intervention for smoking cessation.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Patient Navigation

2017

Completed Phase 2

~38910

Smoking Cessation Intervention

2005

N/A

~1800